We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $751B
1-Year Est. Return 38.74%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+21.29%
1 Year Est. Return
+38.74%
3 Year Est. Return
+107.64%
5 Year Est. Return
+136.97%
10 Year Est. Return
+527.18%
AUM
$751B
AUM Growth
+$96.9B
Cap. Flow
+$16.8B
Cap. Flow %
2.23%
Top 10 Hldgs %
21.83%
Holding
3,591
New
136
Increased
2,145
Reduced
1,132
Closed
153
Avg Time Held
31.7 quarters
Top 10 Avg Time Held
19.9 quarters
Top 20 Avg Time Held
13.5 quarters

Top Buys

Rank Stock Value
1
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$2.6B
2
ABT icon
Abbott
ABT
+$1.29B
3
HD icon
Home Depot
HD
+$1.03B
4
DVN icon
Devon Energy
DVN
+$888M
5
PEP icon
PepsiCo
PEP
+$880M

Sector Composition

Rank Sector Weight
1 Technology 27.11%
2 Financials 10.61%
3 Healthcare 10.33%
4 Miscellaneous 9.93%
5 Industrials 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACTU
3576
Actuate Therapeutics
ACTU
$14.7M
– –
-11,146
Closed -$30.5K –
RZLV
3577
Rezolve AI
RZLV
$796M
– –
-488,130
Closed -$1.25M –
HURA
3578
TuHURA Biosciences
HURA
$125M
– –
-98,937
Closed -$177K –
CIRC
3579
Circle8 Group
CIRC
$56.7M
– –
-13,194
Closed -$40K –
AARD
3580
Aardvark Therapeutics
AARD
$104M
– –
-28,000
Closed -$106K –
DVLT
3581
Datavault AI
DVLT
$133M
– –
-174,967
Closed -$108K –
NXXT
3582
NextNRG Inc
NXXT
$10.9M
– –
-8,708
Closed -$34.8K –
QVCGA
3583
DELISTED
QVC Group Inc Series A
QVCGA
– –
-383,482
Closed -$832K –
SNWV
3584
SANUWAVE Health Inc
SNWV
$48.3M
– –
-21,935
Closed -$379K –
FFAI
3585
Faraday Future Intelligent Electric
FFAI
$6.74M
– –
-2,341
Closed -$96.5K –
SLSN
3586
Solesence Inc
SLSN
$72.1M
– –
-47,387
Closed -$45K –
TVRD
3587
Tvardi Therapeutics
TVRD
$13.7M
– –
-11,784
Closed -$37.5K –
SAFX
3588
XCF Global Inc
SAFX
$130M
– –
-89,675
Closed -$32.8K –
PMI
3589
Picard Medical
PMI
$22.2M
– –
-323
Closed -$16.8K –
AKRE
3590
Akre Focus ETF
AKRE
$4.88B
– –
-5,911
Closed -$312K –
VTIX
3591
Virtuix Holdings Inc
VTIX
$36.3M
– –
-15,000
Closed -$102K –

Similar funds

Charles Schwab's Q2 2026 Portfolio in Review

As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
  • Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
  • Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
  • Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
  • Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
  • Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
  • Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.